Miravant Medical Technologies Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MRVT research report →
Company
Miravant Medical Technologies Inc. operates as a pharmaceutical research and development company. The company develops PhotoPoint, a photodynamic therapy that responds to light destroying cancerous cells; and manufactures light producing and light delivery devices.
- CEO
- David E. Mai
- IPO
- 1995
- Employees
- 47
- HQ
- Santa Barbara, CA, US
Price Chart
Valuation
- Market Cap
- $113.57K
- P/E
- -0.01
- P/S
- 0.00
- P/B
- -0.05
- EV/EBITDA
- -0.37
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 352.89%
- ROIC
- 180.96%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-15,896,000 · -112.94%
- EPS
- $-0.48 · -60.00%
- Op Income
- $13.05M
- FCF YoY
- -3.54%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -7.25
- Avg Volume
- 44
Get TickerSpark's AI analysis on MRVT
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 7, 05 | Sutcliffe Robert J | other | 100,000 |
| Jan 27, 06 | Sutcliffe Robert J | other | 40,000 |
| Jan 27, 05 | PHILPOTT JOHN M | other | 50,393 |
| Jun 21, 04 | EDELMAN JOSEPH | sell | 25,500 |
| Jun 21, 04 | EDELMAN JOSEPH | sell | 2,500 |
| Jun 17, 04 | EDELMAN JOSEPH | sell | 10,000 |
| Jun 16, 04 | EDELMAN JOSEPH | sell | 49,500 |
| Jun 17, 04 | EDELMAN JOSEPH | sell | 22,500 |
| Jun 18, 04 | EDELMAN JOSEPH | sell | 22,500 |
| Jun 17, 04 | EDELMAN JOSEPH | sell | 2,500 |
Our MRVT Coverage
We haven't published any research on MRVT yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate MRVT Report →